Results of a survey relating to the use of Epidiolex (cannabidiol) oral solution in patients with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS) indicates improvement in patient outcomes.Dravet and Lennox-Gastaut syndromes are rare conditions appearing during the first year of life, characterised by frequent fever-related seizures. These seizures tend...

A recently released report from the United Nations Conference On Trade And Development provides an interesting snapshot of the industrial hemp industry.Released last week, the "Commodities At A Glance: Special issue on industrial hemp" looks at the various uses of the crop, production and trade statistics, and how developing...

New Zealand medical cannabis company Helius Therapeutics has been awarded Good Agricultural and Collection Practice (GACP) certification for its facility in East Tamaki, Auckland.GACP guidelines were developed by the World Health Organization (WHO) nearly twenty years ago as part of an effort to improve the quality of medicinal plants/herbal...

As of last Thursday, medical marijuana patients in Rhode Island reportedly no longer need to pay for a medical cannabis card. But they will still pay tax on purchases.Patients no longer having to part with $50 for a card or stump up renewal fees coincides with the commencement of...

A study looking at the prevalence and nature of cannabis use in headache patients attending a Canadian tertiary headache clinic found a significant proportion were finding it helpful. But there were some concerning issues revealed.The researchers – a neurologist and headache specialist from Ontario, another from the Department of...

Australia's Little Green Pharma (ASX:LGP) has received Human Research Ethics Approval for a study to support its efforts towards an Australian Schedule 3 cannabidiol (CBD) product registration.LGP's Phase III efficacy and safety trial involves the company's LGP Classic CBD 50 cannabis medicine, which would target stress reduction and improved...

Findings of an Australian trial of cannabidiol (CBD) oil use for palliative care patients with advanced cancer aren't encouraging.The trial conducted by Mater Research and the University of Queensland investigated symptom relief among 144 patients from the greater Brisbane area. Some patients were given a self-selected dose of CBD...

Many people are interested in medical cannabis - and media coverage could be impacting clinical trial results suggests a new study.Researchers at Sweden's Karolinska Institutet's Department of Clinical Neuroscience analysed 20 published clinical studies in which cannabis has been compared with placebo for clinical pain treatment. They observed no...

Another batch of companies selling cannabidiol-based products are in the crosshairs of the USA's Food and Drug Administration.Last week, the FDA said it had recently posted warning letters to various companies for what it alleges is the illegal sale of products containing cannabidiol (CBD). The agency claims the...

New Zealand medical cannabis company Greenfern Industries (GFI) has a new chairman - Philip Brown.Born and raised in Taranaki*, Mr. Brown takes over from Brent King who announced his resignation on 31 October 2022. The new Chairman is already familiar with the company through a significant shareholding and has...